Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory

NeuroToxicology

Volumn 33, Issue 3, 2012, Pages 491-499

  Melo, Pedro ^a,b   Magalhães, Ana ^a   Alves, Cecília J ^b,c   Tavares, Maria Amélia ^d   de Sousa, Liliana ^e   Summavielle, Teresa ^a,b   Moradas Ferreira, Pedro ^a,e  

^a UNIVERSITY OF PORTO   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^d University of Porto   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Accelerated aging; Methamphetamine; Neurochemistry; Recognition memory

Indexed keywords

DOPAMINE; METHAMPHETAMINE; SEROTONIN; SODIUM CHLORIDE;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; MENTAL PERFORMANCE; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PERINATAL DRUG EXPOSURE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECOGNITION;

AGE FACTORS; AGING; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DOPAMINE; EXPLORATORY BEHAVIOR; HYDROXYINDOLEACETIC ACID; MALE; MEMORY DISORDERS; METHAMPHETAMINE; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); SEROTONIN; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 84861188767     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.03.002     Document Type: Article

References (85)

1. Ali S.F., David S.N., Newport G.D. Age-related susceptibility to MPTP-induced neurotoxicity in mice. Neurotoxicology 1993, 14:29-34.
2. Alves E., Binienda Z., Carvalho F., Alves C.J., Fernandes E., Bastos M.D.L., et al. Acetyl-l-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain. Neuroscience 2009, 158:514-523.
3. Belcher A.M., O'Dell S.J., Marshall J.F. A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Behav Brain Res 2006, 170:167-172.
4. Belcher A.M., Feinstein E.M., O'Dell S.J., Marshall J.F. Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 2008, 33:1453-1463.
5. Bergado J.A., Almaguer W., Rojas Y., Capdevila V., Frey J.U. Spatial and emotional memory in aged rats: a behavioral-statistical analysis. Neuroscience 2011, 172:256-269.
6. Biagioni F., Pellegrini A., Ruggieri S., Murri L., Paparelli A., Fornai F. Behavioural sensitisation during dopamine replacement therapy in Parkinson's disease is reminiscent of the addicted brain. Curr Top Med Chem 2009, 9:894-902.
7. Bisagno V., Ferguson D., Luine V.N. Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res 2002, 940:95-101.
8. Boger H.A., Middaugh L.D., Patrick K.S., Ramamoorthy S., Denehy E.D., Zhu H., et al. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci 2007, 27:8816-8825.
9. Boger H.A., Middaugh L.D., Granholm A.C., McGinty J.F. Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis 2009, 33:459-466.
10. Boguszewski P., Zagrodzka J. Emotional changes related to age in rats - a behavioral analysis. Behav Brain Res 2002, 133:323-332.
11. Bubenikova-Valesova V., Kacer P., Syslova K., Rambousek L., Janovsky M., Schutova B., et al. Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. Int J Dev Neurosci 2009, 27:525-530.
12. Camarasa J., Rodrigo T., Pubill D., Escubedo E. Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats. Pharmacol Res 2010, 62:450-456.
13. Capela J.P., Carmo H., Remiao F., Bastos M.L., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 2009, 39:210-271.
14. Carfagna N., Trunzo F., Moretti A. Brain catecholamine content and turnover in aging rats. Exp Gerontol 1985, 20:265-269.
15. Carnes B.A., Staats D.O., Sonntag W.E. Does senescence give rise to disease?. Mech Ageing Dev 2008, 129:693-699.
16. Carvalho F. How bad is accelerated senescence in consumers of drugs of abuse?. Adicciones 2009, 21:99-104.
17. Chang L., Alicata D., Ernst T., Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102(Suppl. 1):16-32.
18. Cretzmeyer M., Sarrazin M.V., Huber D.L., Block R.I., Hall J.A. Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 2003, 24:267-277.
19. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 1994, 14:2260-2271.
20. Dowling G.J., Weiss S.R.B., Condon T.P. Drugs of abuse and the aging brain. Neuropsychopharmacology 2008, 33:209-218.
21. Eisch A.J., Schmued L.C., Marshall J.F. Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse 1998, 30:329-333.
22. Ennaceur A., Neave N., Aggleton J.P. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 1997, 113:509-519.
23. Ennaceur A., Michalikova S., Bradford A., Ahmed S. Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav Brain Res 2005, 159:247-266.
24. Erickson C.A., Barnes C.A. The neurobiology of memory changes in normal aging. Exp Gerontol 2003, 38:61-69.
25. Esteban S., Garau C., Aparicio S., Moranta D., Barcelo P., Fiol M.A., et al. Chronic melatonin treatment and its precursor l-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res 2010, 48:170-177.
26. Esteban S., Garau C., Aparicio S., Moranta D., Barcelo P., Ramis M., et al. Improving effects of long-term growth hormone treatment on monoaminergic neurotransmission and related behavioral tests in aged rats. Rejuvenation Res 2010, 13:707-716.
27. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 1997, 282:834-838.
28. Friedman S.D., Castaneda E., Hodge G.K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 1998, 61:35-44.
29. Frost D.O., Cadet J.L. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Brain Res Rev 2000, 34:103-118.
30. Fumagalli F., Gainetdinov R.R., Wang Y.M., Valenzano K.J., Miller G.W., Caron M.G. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 1999, 19:2424-2431.
31. Garwood E.R., Bekele W., McCulloch C.E., Christine C.W. Amphetamine exposure is elevated in Parkinson's disease. Neurotoxicology 2006, 27:1003-1006.
32. Gasbarri A., Verney C., Innocenzi R., Campana E., Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res 1994, 668:71-79.
33. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978, 14:633-643.
34. Guilarte T.R. Is methamphetamine abuse a risk factor in parkinsonism?. Neurotoxicology 2001, 22:725-731.
35. Harvey D.C., Lacan G., Tanious S.P., Melega W.P. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 2000, 871:259-270.
36. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 1980, 214:257-262.
37. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 1998, 18:1979-1986.
38. Kalechstein A.D., Newton T.F., Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003, 15:215-220.
39. Kish S.J., Shannak K., Rajput A., Deck J.H., Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem 1992, 58:642-648.
40. Koda L.Y., Gibb J.W. Adrenal and striatal tyrosine hydroxylase activity after methamphetamine. J Pharmacol Exp Ther 1973, 185:42-48.
41. Lu P., Mamiya T., Lu L.L., Mouri A., Niwa M., Kim H.C., et al. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behav Brain Res 2010, 207:387-393.
42. Luine V., Bowling D., Hearns M. Spatial memory deficits in aged rats - contributions of monoaminergic systems. Brain Res 1990, 537:271-278.
43. Luparini M.R., Del Vecchio A., Barillari G., Magnani M., Prosdocimi M. Cognitive impairment in old rats: a comparison of object displacement, object recognition and water maze. Aging (Milano) 2000, 12:264-273.
44. Marshall J.F., Belcher A.M., Feinstein E.M., O'Dell S.J. Methamphetamine-induced neural and cognitive changes in rodents. Addiction 2007, 102:61-69.
45. Melega W.P., Williams A.E., Schmitz D.A., DiStefano E.W., Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 1995, 274:90-96.
46. Melo P., Zanon-Moreno V., Alves C.J., Magalhaes A., Tavares M.A., Pinazo-Duran M.D., et al. Oxidative stress response in the adult rat retina and plasma after repeated administration of methamphetamine. Neurochem Int 2010, 56:431-436.
47. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005, 13:141-154.
48. Metzger R.R., Haughey H.M., Wilkins D.G., Gibb J.W., Hanson G.R., Fleckenstein A.E. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J Pharmacol Exp Ther 2000, 295:1077-1085.
49. Miguez J.M., Aldegunde M., Paz-Valinas L., Recio J., Sanchez-Barcelo E. Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging. J Neural Transm 1999, 106:1089-1098.
50. Moretti A., Carfagna N., Trunzo F. Effect of aging on monoamines and their metabolites in the rat brain. Neurochem Res 1987, 12:1035-1039.
51. Nagai T., Takuma K., Dohniwa M., Ibi D., Mizoguchi H., Kamei H., et al. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology 2007, 194:21-32.
52. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 1992, 581:237-243.
53. Nordahl T.E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition. A review. J Neuropsychiatry Clin Neurosci 2003, 15:317-325.
54. Ossowska K. Disturbances in neurotransmission processes in aging and age-related diseases. Pol J Pharmacol 1993, 45:109-131.
55. Ponzio F., Brunello N., Algeri S. Catecholamine synthesis in brain of ageing rat. J Neurochem 1978, 30:1617-1620.
56. Ponzio F., Calderini G., Lomuscio G., Vantini G., Toffano G., Algeri S. Changes in monoamines and their metabolite levels in some brain regions of aged rats. Neurobiol Aging 1982, 3:23-29.
57. Pradhan S.N. Central neurotransmitters and aging. Life Sci 1980, 26:1643-1656.
58. Reis D.J., Ross R.A., Joh T.H. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse. Brain Res 1977, 136:465-474.
59. Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 1980, 193:153-163.
60. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 1982, 235:93-103.
61. Ricaurte G.A., Fuller R.W., Perry K.W., Seiden L.S., Schuster C.R. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology 1983, 22:1165-1169.
62. Ricaurte G.A., Seiden L.S., Schuster C.R. Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology 1983, 22:1383-1388.
63. Robinson T.E., Yew J., Paulson P.E., Camp D.M. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci Lett 1990, 110:193-198.
64. Rogers J.L., De Santis S., See R.E. Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berl) 2008, 199:615-624.
65. Sabol K.E., Roach J.T., Broom S.L., Ferreira C., Preau M.M. Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res 2001, 892:122-129.
66. Salo R., Ursu S., Buonocore M.H., Leamon M.H., Carter C. Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study. Biol Psychiatry 2009, 65:706-709.
67. Santiago M., Machado A., Reinoso-Suarez F., Cano J. Changes in biogenic amines in rat hippocampus during development and aging. Life Sci 1988, 42:2503-2508.
68. Schroder N., O'Dell S.J., Marshall J.F. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 2003, 49:89-96.
69. Schwendt M., Rocha A., See R.E., Pacchioni A.M., McGinty J.F., Kalivas P.W. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 2009, 331:555-562.
70. Scott J.C., Woods S.P., Matt G.E., Meyer R.A., Heaton R.K., Atkinson J.H., et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 2007, 17:275-297.
71. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 1993, 33:639-677.
72. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001, 158:1206-1214.
73. Simon S.L., Domier C., Carnell J., Brethen P., Rawson R., Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict 2000, 9:222-231.
74. Simon S.L., Dacey J., Glynn S., Rawson R., Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 2004, 27:59-66.
75. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988, 31:959-962.
76. Troen B.R. The biology of aging. Mt Sinai J Med 2003, 70:3-22.
77. Venero J.L., Machado A., Cano J. Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats. J Neurochem 1991, 56:1940-1948.
78. Venero J.L., de la Roza C., Machado A., Cano J. Age-related changes on monoamine turnover in hippocampus of rats. Brain Res 1993, 631:89-96.
79. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001, 158:377-382.
80. Volz T.J., Fleckenstein A.E., Hanson G.R. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 2007, 102(Suppl. 1):44-48.
81. Vorhees C.V., Reed T.M., Morford L.L., Fukumura M., Wood S.L., Brown C.A., et al. Periadolescent rats (P41-50) exhibit increased susceptibility to d-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Neurotoxicol Teratol 2005, 27:117-134.
82. Vupputuri S., Batuman V., Muntner P., Bazzano L.A., Lefante J.J., Whelton P.K., et al. Risk for mild kidney function decline associated with illicit drug use among hypertensive men. Am J Kidney Dis 2004, 43:629-635.
83. Wagner G.C., Ricaurte G.A., Johanson C.E., Schuster C.R., Seiden L.S. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 1980, 30:547-550.
84. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 1980, 181:151-160.
85. White I.M., Minamoto T., Odell J.R., Mayhorn J., White W. Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats. Brain Res 2009, 1266:72-86.